The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet

Diabetologia

Volumn 43, Issue 7, 2000, Pages 875-880

  Kusunoki, M ^a   Hara, T ^a   Tsutsumi, K ^b   Nakamura, T ^c   Miyata, T ^d   Sakakibara, F ^a   Sakamoto, S ^e   Ogawa, H ^a   Nakaya, Y ^e   Storlien, L H ^f  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

^f UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Hormone sensitive lipase; Obesity; Respiratory quotient; Skeletal muscle; Visceral fat

Indexed keywords

4 [(4 BROMO 2 CYANOPHENYL)CARBAMOYL]BENZYLPHOSPHONIC ACID DIETHYL ESTER; LIPOPROTEIN LIPASE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HORMONE ACTION; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RESPIRATORY QUOTIENT; WEIGHT GAIN;

EID: 0033910307     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051464     Document Type: Article

References (26)

1. Popkin BM, Doak CM (1998) The obesity epidemic is a worldwide phenomenon. Nutr Rev 56: 106-114
2. Flatt JP (1995) McCollum Award Lecture, 1995 Diet, lifestyle, and weight maintenance. Am J Clin Nutr 62: 820-836
3. Kern PA, Ong JM, Saffari B, Carty J (1990) The effects of weight loss on the activity and expression of adipose tissue lipoprotein lipase in very obese humans. N Engl J Med 322: 1053-1059
4. Sadur CN, Yost TJ, Eckel RH (1984) Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity. J Clin Endcrinol Metab 59: 1176-1178
5. Tsutsumi K, Inoue Y, Shima A, Iwasaki K, Kawamura M, Murase T (1993) The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J Clin Invest 92: 411-417
6. Tsutsumi K, Inoue Y, Shima A, Murase T (1995) Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes 44: 414-417
7. Tsutsumi K, Inoue Y, Hagi A, Murase T (1997) The novel compound NO-1886 elevates plasma high-density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase without any effect on cholesteryl ester transfer protein activity. Metabolism 46: 257-260
8. Hara T, Cameron-Smith D, Cooney GJ, Kusunoki M, Tsutsumi K, Storlien LH (1998) The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose fed rats. Metabolism 47: 149-153
9. Murase T, Uchimura H (1980) A selective decline of post-heparin plasma hepatic triglyceride lipase in hypothyroid rats. Metabolism 29: 797-801
10. Murase T, Yamada N, Matsuzaki F (1981) The in vitro effect of growth hormone on adipose tissue lipoprotein lipase in rats. Life Sci 28: 199-201
11. Rizack MA (1961) An epinephrine-sensitive lipolytic activity in adipose tissue. J Biol Chem 236: 657-662
12. Holm C, Kirchgessner TG, Svenson KL, Lusis AJ, Belfrage P, Schotz C (1988) Nucleotide sequence of rat adipose hormone sensitive lipase cDNA. Nucleic Acid Res 16: 9879
13. Sambrook J, Fritsch EF, Maniatis T (1989) Extraction, purification and analysis of messenger RNA from eukaryotic cells. In Molecular Cloning, 2nd edn. Cold Springs Harbor Laboratory, Cold Springs Harbor, New York, pp 1-87
14. Eckel RH (1989) Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320: 1060-1068
15. Jensen DR, Schlaepfer IR, Morin CL et al. (1997) Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol 273: R683-R689
16. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipids. Diabetes 40: 280-289
17. Phillips DI, Caddy S, Ilic V et al. (1996) Intramuscular triglyceride and muscle insulin senstivity:evidence for a relationship in nondiabetic subjects. Metabolism 45: 947-50, 1996
18. Pan DA, Lillioja S, Kriketos AD et al. (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988
19. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE (1999) Markers of capacity to utilize fatty acids in human skeletal muscle:relation to insulin resistance and obesity and effects of weight loss. FASEB J 13: 2051-2060
20. Shimada M, Ishibashi S, Yamamoto K et al. (1995) Overexpression of human lipoprotein lipase increases hormone-sensitive lipase activity in adipose tissue of mice. Biochem Biophys Res Commun 211: 761-766
21. Shimomura Y, Tamura T, Suzuki M (1990) Less body fat accumulation in rats fed a safflower oil diet than in rats fed a beef tallow diet. J Nutr 120: 1291-1296
22. Matsuo T, Suzuki M (1997) Brain beta-adrenergic receptor binding in rats with obesity induced by a beef tallow diet. Metabolism 46: 18-22
23. Eckel RH, Jensen DR, Schlaepfer IR, Yost TJ (1996) Tissue-specific regulation of lipoprotein lipase by isoproterenol in normal-weight humans. Am J Physiol 271: R1280-R1286
24. Ferraro RT, Eckel RH, Larson DE et al. (1993) Relationship between skeletal muscle lipoprotein lipase activity and 24-h macronutrient oxidation. J Clin Invest 92: 441-445
25. Zurlo F, Ravussin E (1992) A low rate of fat utilization as a predictor of weight gain. In: Belfiore F, Jeanrenaud B, Papalia D (eds) Obesity: Basic Concepts and Clinical Aspects. Karger, Basel, pp 50-60
26. Astrup A, Buemann B, Christensen NJ, Toubro S (1994) Failure to increase lipid oxidation in response to increasing dietary fat content in formely obese women. Am J Physiol 266: E592-E599